Review
Jul 2026
Epitranscriptomic regulation in the progression of cancer and platinum resistance.
Preclinical studies demonstrate that pharmacological inhibition of key regulators, such as METTL3 inhibitors (STC-15, STM2457, UZH2) or FTO inhibitors, can sensitize tumors to platinum drugs and stimulate anti-tumor immunity.
P. Harvanik, T. Hudáková, M. Šemeláková et al.
· Advances in Medical Sciences · 1 citation